More than a decade after its foundation, Batist Medical Portugal continues its consolidation in the domestic market. After an atypical year of 2020 in which sales volume exceeded expectations, doubling its value, the results for 2021 demonstrate an expected normalization in the market, in which BATIST® Portugal experienced a positive evolution compared to the pre-pandemic period, thus maintaining the growth trend that was seen before the emergence and impacts of covid-19.
The company's current strategy is focused on offering innovative products and solutions, which, due to the clinical results obtained, will create a positive impact on the quality of life of patients and allow better management of hospital resources, thus improving their efficiency and, consequently, reducing costs associated with some pathologies.
Fruit of the exclusive representation of international brands to the Iberian Peninsula, 2014 was to BATIST® also the year of investment in exploration of Spanish market. The proximity to a higher market than the Portuguese and the good results obtained in Portugal did foresee a notable success in this goal.
Once the maintenance of importance in providing the great Spanish hospitals is a reality, BATIST® PORTUGAL was a major impediment to participation in public tenders launched in Spain, a country strongly "nationalist" where there’s a clear preference for Spanish national suppliers. Aware of this, BATIST® created in May 2014 the BATIST® SPAIN, an entity under Spanish law, especially dedicated to the activity in the market in that country, whose main supplier is the BATIST® Portugal.
Send us an email
+351 229 429 520
national landline call (PT)
+351 933 032 604
national mobile call (PT)
Rua de Cidres, 1473